Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Devyser Diagnostics AB (DVYSR) Stock Price & Analysis

1 Followers

DVYSR Stock Chart & Stats

SEK 64.80SEK 3.30(5.37%)
At close: 5:30 PM GMT+1
kr 50kr 55kr 60kr 65Aug 10Aug 24Sep 7Sep 21Oct 5Oct 19Nov 2
Day’s Range
SEK 62.00 - SEK 68.00
52-Week Range
SEK 48.50 - SEK 124.00
Previous Close
SEK 61.50
Volume
N/A
Average Volume (3M)
25.32K
Market Cap
SEK 1.04B
Enterprise Value
SEK 813.30M
Total Cash (Recent Filing)
SEK 81.00M
Total Debt (Recent Filing)
SEK 45.80M
Price to Earnings (P/E)
70.4
Beta
0.55
Next Earnings
Feb 16, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Profitability Turnaround

The return to positive earnings and improved operating margins marks a meaningful recovery from recent losses. If maintained, stronger profitability can support internal reinvestment, improve resilience, and provide a more durable earnings base over the next several quarters.

Very Strong Gross Margin

An approximately 80% gross margin indicates substantial value capture in Devyser’s diagnostic products and supports attractive economics as assay volumes grow. This margin profile can help fund product development, commercial expansion, and ongoing innovation in clinical testing.

Conservative Leverage

Low leverage and declining debt give Devyser financial flexibility while limiting interest and refinancing pressure. A stronger equity cushion can help the company fund laboratory adoption and product expansion internally, while improving its ability to withstand uneven operating performance.

Bears Say

Weak Top-line Growth

Revenue contraction suggests the earnings recovery is currently driven more by cost and margin improvement than by expanding demand. Without renewed top-line growth, the company may have less operating leverage and fewer opportunities to compound earnings over the medium term.

Uneven Cash Conversion

Although operating and free cash flow are positive, the reported conversion ratio indicates that accounting earnings are not translating consistently into cash. Continued conversion volatility could constrain self-funded investment and make the quality of the turnaround less dependable.

Modest Returns On Equity

Positive but modest return on equity shows that the profitability recovery has not yet produced strong returns on the company’s capital base. The history of negative annual returns also indicates that management must sustain improvement before operational performance can be viewed as fully established.

DVYSR FAQ

What was Devyser Diagnostics AB’s price range in the past 12 months?
Devyser Diagnostics AB lowest stock price was kr 48.50 and its highest was kr 124.00 in the past 12 months.
What is Devyser Diagnostics AB’s market cap?
Devyser Diagnostics AB’s market cap is kr 1.04B.
When is Devyser Diagnostics AB’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Devyser Diagnostics AB’s earnings last quarter?
Devyser Diagnostics AB released its earnings results on Nov 03, 2026. The company reported kr 0.432 earnings per share for the quarter, missing the consensus estimate of kr 0.45 by -kr 0.018.
Is Devyser Diagnostics AB overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Devyser Diagnostics AB pay dividends?
Devyser Diagnostics AB does not currently pay dividends.
What is Devyser Diagnostics AB’s EPS estimate?
Devyser Diagnostics AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Devyser Diagnostics AB have?
Devyser Diagnostics AB has 16,889,807 shares outstanding.
What happened to Devyser Diagnostics AB’s price movement after its last earnings report?
Devyser Diagnostics AB reported an EPS of kr 0.432 in its last earnings report, missing expectations of kr 0.45. Following the earnings report the stock price went up 5.366%.
Which hedge fund is a major shareholder of Devyser Diagnostics AB?
Currently, no hedge funds are holding shares in SE:DVYSR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology